Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Personalis Establishes UK Subsidiary and Appoints Mark Dronsfield as Director of European Sales

Published: Wednesday, September 25, 2013
Last Updated: Wednesday, September 25, 2013
Bookmark and Share
Personalis announced the formation of its UK subsidiary, Personalis UK Limited, to better serve the needs of customers across Europe.

The company also announced the appointment of Mark Dronsfield, Ph.D., as Director of European Sales.

“Given the expanding research and clinical demands for large scale exome and genome analysis, we felt it was important to augment our presence in the European markets,” said Personalis CEO John West.  “We wanted to be prepared to build infrastructure on both the commercial and operational sides, so we are best able to address the needs of researchers and clinicians.”

West continued, “We are especially pleased to open our UK subsidiary as two of our major investors, Abingworth Management LLP and Dr. Herman Hauser, FRS, are UK-based.” Both Abingworth and Dr. Hauser’s Amadeus venture fund were investors in Solexa, Ltd, inventor of the sequencing-by-synthesis technology at the core of Illumina’s sequencing systems today. Abingworth’s Dr. Jonathan MacQuitty currently serves as Personalis’ Chairman.

Initially, Personalis intends to build out its commercial team, but will also build services infrastructure in the UK as customers’ needs require.

Mark Dronsfield, Personalis’ newly appointed Director of European Sales, was most recently Head of Commercial Operations Europe for RainDance Technologies and has also held European commercial operations positions for Illumina, Affymetrix and Life Technologies.

“We believe that the combination of Personalis’ deep expertise in exome/genome sequencing and analysis, along with a direct presence in Europe, will open many new opportunities as the clinical demand for next generation sequencing rapidly grows,” said Dronsfield.  “I am really excited to be part of Personalis’ European expansion.”


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,100+ scientific posters on ePosters
  • More Than 4,500+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Personalis and the Garvan Institute Partner
Collaboration to bring together high-quality, large-scale whole genome sequencing with best-in-class analysis and interpretation services for research and clinical applications.
Wednesday, October 22, 2014
Scientific News
The Rise of 3D Cell Culture and in vitro Model Systems for Drug Discovery and Toxicology
An overview of the current technology and the challenges and benefits over 2D cell culture models plus some of the latest advances relating to human health research.
World’s Largest Coral Gene Database
‘Genetic toolkit’ will help shed light on which species survive climate change.
A Boost for Regenerative Medicine
Growing tissues and organs in the lab for transplantation into patients could become easier after scientists discovered an effective way to produce three-dimensional networks of blood vessels, vital for tissue survival yet a current stumbling block in regenerative medicine.
Breast Cancer Drug Hope
A drug for breast cancer that is more effective than existing medicines may be a step closer thanks to new research.
Untangling Disease-Related Protein Misfolding
Work advances understanding of genetic forms of thrombosis, emphysema, cirrhosis of the liver, neurodegenerative diseases and inflammation, among others.
Early Genetic Changes in Premalignant Colorectal Tissue Identified
Findings point to drivers of early cancer development, targets for cancer prevention therapies.
Harnessing Nature’s Vast Array of Venoms for Drug Discovery
Scripps scientists have developed a method for rapidly identifying venoms.
Nanoparticles Target, Transform Fat Tissue
Nanoparticles designed to target white fat and convert it to calorie-burning brown fat slowed weight gain in obese mice without affecting food intake. This proof-of-concept work could lead to new therapies to treat obesity.
New Cancer Fighters Emerge From Lab
Rice University lab simplifies total synthesis of anti-cancer agent.
Scientists Find Evidence That Cancer Can Arise Changes
Researchers at Rockefeller University have found a mutation that affects the proteins that package DNA without changing the DNA itself can cause a rare form of cancer.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,100+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!